Accelrys, Inc. (NASDAQ: ACCL), a leading global provider of scientific
business intelligence software and services, announced that its Board of
Directors has named Scipio “Max” Carnecchia to serve as the Company’s
Chief Executive Officer and President, effective today. Mr. Carnecchia
has also been appointed to the Company’s Board of Directors.
Mr. Carnecchia comes to Accelrys with more than two decades of high
technology experience. Most recently he served as President of
Interwoven, a global leader in content management solutions. At
Interwoven, he ran the day to day operations of the business and led the
company through 21 consecutive quarters of year over year revenue growth
and operating margin expansion. Interwoven was acquired by Autonomy
Corporation plc earlier this year in a transaction valued at
approximately $800 million.
Todd Johnson, who has served as Accelrys’ interim President and Chief
Executive Officer, is resigning his position effective June 15, 2009. He
will serve as an advisor to Mr. Carnecchia for a period of time to
assist with the transition. Mr. Johnson was named interim President and
CEO in January 2009.
Ken Coleman, Chairman of Accelrys’ Board of Directors, commented: “Max
brings to Accelrys strong execution skills, a proven ability to develop
performing teams and a solid track record of driving shareholder value.”
In commenting on his appointment, Mr. Carnecchia stated: “Accelrys
is a solid company with a great collection of assets, strong technology
and a talented team. I look forward to working with the team to take the
company to its full potential."
Prior to Interwoven, Carnecchia served as Vice President of Global Sales
of Xoriant Corporation, Vice President of Sales and Services of SmartDB
Corporation, and as Vice President of Sales for Group 1 Software. He
received a Bachelor of Engineering in Electrical Engineering and
Computer Science from The Stevens Institute of Technology.
About Accelrys:
Headquartered in San Diego, California, Accelrys develops scientific
business intelligence software and solutions for the life sciences,
energy, chemicals, aerospace, and consumer products industries. Our
customers include many Fortune 500 companies and other commercial
entities, as well as academic and government entities. We have a vast
portfolio of computer-aided design modeling and simulation offerings
which assist our customers in conducting scientific experiments ‘in
silico’ in order to reduce the duration and cost of discovering and
developing new drugs and materials.
